Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 99

1.

Cardiovascular Risk Prediction in CKD.

Ballew SH, Matsushita K.

Semin Nephrol. 2018 May;38(3):208-216. doi: 10.1016/j.semnephrol.2018.02.002. Review.

PMID:
29753398
2.

Cardiac and kidney markers for cardiovascular prediction in individuals with chronic kidney disease: the Atherosclerosis Risk in Communities study.

Matsushita K, Sang Y, Ballew SH, Astor BC, Hoogeveen RC, Solomon SD, Ballantyne CM, Woodward M, Coresh J.

Arterioscler Thromb Vasc Biol. 2014 Aug;34(8):1770-7. doi: 10.1161/ATVBAHA.114.303465. Epub 2014 May 29.

3.

Cardiovascular risk prediction in people with chronic kidney disease.

Matsushita K, Ballew SH, Coresh J.

Curr Opin Nephrol Hypertens. 2016 Nov;25(6):518-523. Review.

4.

Effect Modification of Chronic Kidney Disease on the Association of Circulating and Imaging Cardiac Biomarkers With Outcomes.

Gregg LP, Adams-Huet B, Li X, Colbert G, Jain N, de Lemos JA, Hedayati SS.

J Am Heart Assoc. 2017 Jul 5;6(7). pii: e005235. doi: 10.1161/JAHA.116.005235.

5.

Filtration Markers as Predictors of ESRD and Mortality: Individual Participant Data Meta-Analysis.

Inker LA, Coresh J, Sang Y, Hsu CY, Foster MC, Eckfeldt JH, Karger AB, Nelson RG, Liu X, Sarnak M, Appel LJ, Grams M, Xie D, Kimmel PL, Feldman H, Ramachandran V, Levey AS; CKD Biomarkers Consortium.

Clin J Am Soc Nephrol. 2017 Jan 6;12(1):69-78. doi: 10.2215/CJN.03660316. Epub 2016 Nov 10.

6.

Serum β-Trace Protein and β2-Microglobulin as Predictors of ESRD, Mortality, and Cardiovascular Disease in Adults With CKD in the Chronic Renal Insufficiency Cohort (CRIC) Study.

Foster MC, Coresh J, Hsu CY, Xie D, Levey AS, Nelson RG, Eckfeldt JH, Vasan RS, Kimmel PL, Schelling J, Simonson M, Sondheimer JH, Anderson AH, Akkina S, Feldman HI, Kusek JW, Ojo AO, Inker LA; CKD Biomarker Consortium and the CRIC Study Investigators.

Am J Kidney Dis. 2016 Jul;68(1):68-76. doi: 10.1053/j.ajkd.2016.01.015. Epub 2016 Mar 3.

7.

NT-proBNP and troponin T and risk of rapid kidney function decline and incident CKD in elderly adults.

Bansal N, Katz R, Dalrymple L, de Boer I, DeFilippi C, Kestenbaum B, Park M, Sarnak M, Seliger S, Shlipak M.

Clin J Am Soc Nephrol. 2015 Feb 6;10(2):205-14. doi: 10.2215/CJN.04910514. Epub 2015 Jan 20.

8.

GFR Estimation Using β-Trace Protein and β2-Microglobulin in CKD.

Inker LA, Tighiouart H, Coresh J, Foster MC, Anderson AH, Beck GJ, Contreras G, Greene T, Karger AB, Kusek JW, Lash J, Lewis J, Schelling JR, Navaneethan SD, Sondheimer J, Shafi T, Levey AS.

Am J Kidney Dis. 2016 Jan;67(1):40-8. doi: 10.1053/j.ajkd.2015.07.025. Epub 2015 Sep 9.

9.

The Chronic Kidney Disease Epidemiology Collaboration (CKD-EPI) equation incorporating both cystatin C and creatinine best predicts individual risk: a cohort study in 444 patients with chronic kidney disease.

Rogacev KS, Pickering JW, Seiler S, Zawada AM, Emrich I, Fliser D, Heine GH.

Nephrol Dial Transplant. 2014 Feb;29(2):348-55. doi: 10.1093/ndt/gft422. Epub 2013 Oct 28.

PMID:
24166454
10.

Level of urinary liver-type fatty acid-binding protein is associated with cardiac markers and electrocardiographic abnormalities in type-2 diabetes with chronic kidney disease stage G1 and G2.

Maeda Y, Suzuki A, Ishii J, Sekiguchi-Ueda S, Shibata M, Yoshino Y, Asano S, Hayakawa N, Nakamura K, Akiyama Y, Kitagawa F, Sakuishi T, Fujita T, Hashimoto S, Ozaki Y, Itoh M.

Heart Vessels. 2015 May;30(3):362-8. doi: 10.1007/s00380-014-0489-4. Epub 2014 Mar 14.

PMID:
24626813
11.

Cystatin C and estimated glomerular filtration rate as predictors for adverse outcome in patients with ST-elevation and non-ST-elevation acute coronary syndromes: results from the Platelet Inhibition and Patient Outcomes study.

Akerblom Å, Wallentin L, Siegbahn A, Becker RC, Budaj A, Buck K, Giannitsis E, Horrow J, Husted S, Katus HA, Steg PG, Storey RF, Åsenblad N, James SK.

Clin Chem. 2012 Jan;58(1):190-9. doi: 10.1373/clinchem.2011.171520. Epub 2011 Nov 29.

12.

Risk prediction of major complications in individuals with diabetes: the Atherosclerosis Risk in Communities Study.

Parrinello CM, Matsushita K, Woodward M, Wagenknecht LE, Coresh J, Selvin E.

Diabetes Obes Metab. 2016 Sep;18(9):899-906. doi: 10.1111/dom.12686. Epub 2016 Jun 14.

13.

Combining Cystatin C and Creatinine Yields a Reliable Glomerular Filtration Rate Estimation in Older Adults in Contrast to β-Trace Protein and β2-Microglobulin.

Werner K, Pihlsgård M, Elmståhl S, Legrand H, Nyman U, Christensson A.

Nephron. 2017;137(1):29-37. doi: 10.1159/000473703. Epub 2017 Apr 14.

PMID:
28407629
14.

[Evaluation and application of estimation of glomerular filtration rate based on serum creatinine and cystatin C in renal function staging].

Shen ZX, Liu Y, Liu M, Zheng H, Wu XJ, Shen C.

Zhonghua Liu Xing Bing Xue Za Zhi. 2017 Nov 10;38(11):1557-1562. doi: 10.3760/cma.j.issn.0254-6450.2017.11.024. Chinese.

PMID:
29141349
15.

Cystatin C-based CKD-EPI equations and N-terminal pro-B-type natriuretic peptide for predicting outcomes in acutely decompensated heart failure.

Flores-Blanco PJ, Manzano-Fernández S, Pérez-Calvo JI, Pastor-Pérez FJ, Ruiz-Ruiz FJ, Carrasco-Sánchez FJ, Morales-Rull JL, Pascual-Figal D, Galisteo-Almeda L, Januzzi JL.

Clin Cardiol. 2015 Feb;38(2):106-13. doi: 10.1002/clc.22362. Epub 2015 Feb 6.

16.

Change in Multiple Filtration Markers and Subsequent Risk of Cardiovascular Disease and Mortality.

Rebholz CM, Grams ME, Matsushita K, Inker LA, Foster MC, Levey AS, Selvin E, Coresh J.

Clin J Am Soc Nephrol. 2015 Jun 5;10(6):941-8. doi: 10.2215/CJN.10101014. Epub 2015 Mar 30.

17.

Early markers of cardiovascular risk in chronic kidney disease.

Lai S, Dimko M, Galani A, Coppola B, Innico G, Frassetti N, Mazzei ED, Mariotti A.

Ren Fail. 2015 Mar;37(2):254-61. doi: 10.3109/0886022X.2014.982489. Epub 2014 Nov 14.

PMID:
25394527
18.

Chronic kidney disease predicts coronary plaque vulnerability: an optical coherence tomography study.

Dai J, Xing L, Hou J, Jia H, Hu S, Tian J, Lin L, Li L, Zhu Y, Zheng G, Zhang S, Yu B, Jang IK.

Coron Artery Dis. 2017 Mar;28(2):135-144. doi: 10.1097/MCA.0000000000000452.

PMID:
27922522
19.

Clinical utility of creatinine- and cystatin C-based definition of renal function for risk prediction of primary cardiovascular events in patients with diabetes.

Schöttker B, Herder C, Müller H, Brenner H, Rothenbacher D.

Diabetes Care. 2012 Apr;35(4):879-86. doi: 10.2337/dc11-1998. Epub 2012 Feb 14.

20.

Supplemental Content

Support Center